Orla McNally

Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy

Paul A Cohen, Yee Leung, Lyndal Anderson, Rachael van der Griend, Paola Chivers, Sanela Bilic, Sophie Bittinger, Alison Brand, Max K Bulsara, Jim Codde, Lois Eva, Louise Farrell, Dianne Harker, Unine Herbst, Stephanie Jeffares, Diane Loh, Orla McNally, Ganendra Raj Mohan, Tarryn Nicholson, Aime Powell, et al.

Journal article  |  2020  |  Gynecologic Oncology

OBJECTIVE: Adenocarcinoma in situ (AIS) of the cervix is a precursor to cervical adenocarcinoma. When AIS is detected by cervical ..

EARLY STAGE, LOW GRADE ENDOMETRIAL ADENOCARCINOMA IN REPRODUCTIVE AGED WOMEN. AN EVALUATION OF PATIENT PERSPECTIVES OF DIAGNOSIS, TREATMENT DECISION MAKING, MANAGEMENT, FERTILITY AND SURVIVORSHIP: A QUALITATIVE STUDY

Alina Roman, Michelle Peate, Yasmin Jayasinghe, Orla M Mcnally

Conference Proceedings  |  2020  |  International Journal of Gynecological Cancer

SENTINEL LYMPH NODE DETECTION WITH INDOCYANINE GREEN AND PATENT BLUE DYE IN CERVICAL CANCER: A RETROSPECTIVE STUDY

R McBain, O McNally, D Neesham, A Jones, A Richards

Conference Proceedings  |  2020  |  International Journal of Gynecological Cancer

Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care.

Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, et al.

Journal article  |  2020  |  International Journal of Gynecological Cancer

INTRODUCTION: The International Cancer Benchmarking Partnership demonstrated international differences in ovarian cancer survival,..

PATTERNS OF RECURRENCE IN LOW-RISK ENDOMETRIAL CANCER- EVIDENCE FOR A CHANGE IN FOLLOW-UP

Y Naaman, T Hodge, A Jones, F Chin, D Neesham, O McNally

Conference Proceedings  |  2020  |  International Journal of Gynecological Cancer

CONSERVATIVE SURGERY IN FERTILITY SPARING MANAGEMENT OF EARLY STAGE CERVICAL CANCERS - A REVIEW OF ONCOLOGIC AND REPRODUCTIVE OUTCOMES AT A TERTIARY CENTRE IN AUSTRALIA

F Chin, N Siddique, S Kathurusinghe, O McNally, D Neesham

Conference Proceedings  |  2020  |  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

New approaches to cancer care in a COVID-19 world

John Butler, Christian Finley, Charles H Norell, Samantha Harrison, Heather Bryant, Michael P Achiam, Alon D Altman, Nancy Baxter, James Bentley, Paul A Cohen, M Asif Chaudry, Elijah Dixon, Rhonda Farrell, Scott Fegan, Salila Hashmi, Claus Hogdall, John T Jenkins, Janice Kwon, Tom Mala, Orla McNally, et al.

Journal article  |  2020  |  The Lancet Oncology

Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care

Luke McLean, James R Whittle, Jonathan Graham, Huda Ismail, Meir Lichtenstein, Rodney J Hicks, Orla McNally, Alan Herschtal, Mark Rosenthal, Danny Rischin, Anne Hamilton

Journal article  |  2020  |  Gynecologic Oncology

BACKGROUND: Glomerular filtration rate (GFR) measured by Chromium-51-EDTA excretion (51Cr-GFR) is considered the gold standard of ..

Therapeutic options for mucinous ovarian carcinoma

Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, David DL Bowtell, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Sian Fereday, C Blake Gilks, Charlie Gourley, Alison M Hadley, Joy Hendley, Sally M Hunter, Scott H Kaufmann, et al.

Journal article  |  2020  |  Gynecologic Oncology

OBJECTIVE: Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemother..

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer.

Nirmala Chandralega Kampan, Mutsa Tatenda Madondo, John Reynolds, Julene Hallo, Orla M McNally, Thomas W Jobling, Andrew N Stephens, Michael A Quinn, Magdalena Plebanski

Journal article  |  2020  |  Scientific Reports

Pre-operative discrimination of malignant masses is crucial for accurate diagnosis and prompt referral to a gynae oncology centre ..